Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Greece, China and earnings will dominate next week's trading, Jim Cramer told his Mad Money viewers Friday as he laid out his game plan.

On Monday, Cramer said the markets will of course be focused on Greece and whether there's a deal with the rest of Europe. Then there's China, where it's not the direction but the velocity of the move that investors will be following.

Next, on Tuesday, it's Johnson & Johnson (JNJ), a stock Cramer owns for his charitable trust, Action Alerts PLUS, reporting earnings. With shares down 4.8% for the year, Cramer said this stock is too cheap. Also on Tuesday, JPMorgan Chase (JPM) and Wells Fargo (WFC), along with Yum! Brands (YUM). Cramer said the markets are only looking at net interest margins for the banks, which will remain poor, and Yum! is levered to China, which will also likely be under pressure.

Then, on Wednesday, it's Bank of America (BAC), Netflix (NFLX) and Delta Airlines (DAL) reporting. Cramer felt Netflix might work after receiving three upgrades this week, but his recommendation was to buy Delta.

Thursday brings earnings from Google (GOOGL), another Action Alerts PLUS name, as well as Domino's Pizza (DPZ) and Schlumberger (SLB). Cramer remains a fan of both Google and Domino's.

Finally, on Friday, it's General Electric (GE) and Cramer fave and AAP holding Honeywell (HON) in the spotlight. Cramer is bullish on Honeywell.

Not Bullish on China Stocks

China is in trouble and everybody knows it, Cramer told viewers. After a vicious month-long selloff, the only thing that seems to be keeping Chinese stocks from falling further are stringent government-mandated rules restricting short sellers and new stock issues.

That's bad news for the entire Chinese economy, with sales of everything from autos to cellphones likely to slow.

But with stocks like Baidu.com (BIDU) and Alibaba (BABA) already down big, is now the time to start buying?

Cramer said there's no doubt the Chinese have screwed up their growth plans, but historically, it's been a mistake to underestimate their ability to act quickly and keep their economy growing, if for no other reason than to maintain order.

So is now the time to buy? Cramer said he's not convinced quite yet, but he certainly understands the logic behind the China bulls.

Hooray for Kraft Heinz

While the markets have been focused on Greece, a new king of packaged foods has been crowned, and it's the new Kraft Heinz (KHC).

For those not familiar with the story, Heinz was taken private by Warren Buffet in 2013. The company then agreed to merge with Kraft, and that new entity is now trading as KHC.

The new Kraft Heinz is a powerhouse, Cramer told viewers, with a stable of the best brands and a solid management team that knows how to bring those brands to the rest of the world. Shares of Kraft Heinz also sport a 2.9% dividend.

Cramer said he was a big fan of the Heinz management team because they've been aggressively cutting costs, improving margins and bolstering the company's bottom line. Shares currently trade at 23 times estimates, but Cramer said given its international opportunities, $90 or even $100 a share could be in the stock's future.

Cramer and ConforMis

The company with the best technology doesn't always win, Cramer told viewers as he followed up on ConforMIS (CFMS), the medical device maker with the "holy grail" of knee replacements, a fully customized implant.

Cramer interviewed ComforMIS' CEO July 1 and since then the stock is up a quick 16%. But does it deserve to be?

Cramer said there's no doubt that ConforMIS has the winning technology, which is backed by no less than 470 patents. But it's also up against large, established competitors like Johnson & Johnson, Stryker (SYK), Zimmer Biomet (ZBH) and Smith & Nephew (SNN).

All of these companies have decades-long relationships with surgeons as well as royalty programs and deep pockets for rewarding repeat business. These rivals are also innovating, having increased the number of implant options from five to 15. That's nowhere near "custom," but it does make ConforMIS a small fish in a very large pond with improving competition.

That said, Cramer noted that it appears ConforMIS is making inroads, having grown revenue by 36%, even with the established headwinds. That means the stock can head still higher.

Lightning Round

In the Lightning Round, Cramer was bullish on Cypress Semiconductor (CY).

Cramer was bearish on Linn Energy (LINE), DuPont (DD), Puma Biotechnology (PBYI) and Barracuda Networks (CUDA).

Off the Tape

In his "Off the Tape" segment, Cramer sat down with Tri Tran, CEO of the privately held Munchery, an online service for local meal delivery. Munchery currently operates in just four cities, Los Angeles, New York, San Francisco and Seattle, but just raised $85 million in funding.

Tran said that Munchery enables its customers to order meals on the go and have them delivered right to their door. But unlike a traditional restaurant that makes individual meals, Munchery makes hundreds of meals at a time, benefitting from needing only one large kitchen and buying in bulk. The meals are then chilled so they can be reheated by customers for a great experience.

Tran said that Munchery is growing quickly at all of its locations, but maintains a "quality first" mantra for all of their healthy dining options.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in GOOGL, HON, JNJ and WFC.

More from Jim Cramer

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Using Technical Analysis to Profit: Cramer's 'Mad Money' Recap (Friday 7/20/18)

Using Technical Analysis to Profit: Cramer's 'Mad Money' Recap (Friday 7/20/18)

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Target, US Bancorp, BlackRock: 'Mad Money' Lightning Round

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)